nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—HPGDS—urinary bladder cancer	0.541	1	CbGaD
Dinoprost Tromethamine—SLCO3A1—Methotrexate—urinary bladder cancer	0.0862	0.347	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Fluorouracil—urinary bladder cancer	0.0491	0.198	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Cisplatin—urinary bladder cancer	0.0297	0.119	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—urinary bladder cancer	0.0284	0.114	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—urinary bladder cancer	0.0271	0.109	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—urinary bladder cancer	0.0165	0.0665	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—urinary bladder cancer	0.0115	0.0463	CbGbCtD
Dinoprost Tromethamine—HPGDS—urine—urinary bladder cancer	0.00528	0.0754	CbGeAlD
Dinoprost Tromethamine—TBXA2R—prostate gland—urinary bladder cancer	0.00285	0.0407	CbGeAlD
Dinoprost Tromethamine—GALR3—female reproductive system—urinary bladder cancer	0.00263	0.0375	CbGeAlD
Dinoprost Tromethamine—SLC22A8—urine—urinary bladder cancer	0.00237	0.0338	CbGeAlD
Dinoprost Tromethamine—PTGER3—prostate gland—urinary bladder cancer	0.00219	0.0313	CbGeAlD
Dinoprost Tromethamine—TBXA2R—epithelium—urinary bladder cancer	0.00209	0.0299	CbGeAlD
Dinoprost Tromethamine—TBXA2R—urethra—urinary bladder cancer	0.00191	0.0272	CbGeAlD
Dinoprost Tromethamine—HPGDS—prostate gland—urinary bladder cancer	0.0019	0.0271	CbGeAlD
Dinoprost Tromethamine—PTGFR—prostate gland—urinary bladder cancer	0.00175	0.025	CbGeAlD
Dinoprost Tromethamine—PTGER1—renal system—urinary bladder cancer	0.0017	0.0244	CbGeAlD
Dinoprost Tromethamine—TBXA2R—female reproductive system—urinary bladder cancer	0.00156	0.0222	CbGeAlD
Dinoprost Tromethamine—PTGER3—smooth muscle tissue—urinary bladder cancer	0.00155	0.0222	CbGeAlD
Dinoprost Tromethamine—PTGIR—prostate gland—urinary bladder cancer	0.00155	0.0221	CbGeAlD
Dinoprost Tromethamine—PTGER3—renal system—urinary bladder cancer	0.00149	0.0214	CbGeAlD
Dinoprost Tromethamine—TBXA2R—vagina—urinary bladder cancer	0.00141	0.0201	CbGeAlD
Dinoprost Tromethamine—HPGDS—epithelium—urinary bladder cancer	0.00139	0.0199	CbGeAlD
Dinoprost Tromethamine—PTGER1—female reproductive system—urinary bladder cancer	0.00137	0.0195	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—prostate gland—urinary bladder cancer	0.00136	0.0195	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—prostate gland—urinary bladder cancer	0.00135	0.0193	CbGeAlD
Dinoprost Tromethamine—Dinoprostone—HPGDS—urinary bladder cancer	0.0013	0.688	CrCbGaD
Dinoprost Tromethamine—HPGDS—renal system—urinary bladder cancer	0.00129	0.0185	CbGeAlD
Dinoprost Tromethamine—HPGDS—urethra—urinary bladder cancer	0.00127	0.0181	CbGeAlD
Dinoprost Tromethamine—PTGFR—smooth muscle tissue—urinary bladder cancer	0.00124	0.0177	CbGeAlD
Dinoprost Tromethamine—PTGER3—female reproductive system—urinary bladder cancer	0.0012	0.0171	CbGeAlD
Dinoprost Tromethamine—PTGFR—urethra—urinary bladder cancer	0.00117	0.0168	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—seminal vesicle—urinary bladder cancer	0.00115	0.0165	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—seminal vesicle—urinary bladder cancer	0.00114	0.0163	CbGeAlD
Dinoprost Tromethamine—PTGIR—epithelium—urinary bladder cancer	0.00114	0.0162	CbGeAlD
Dinoprost Tromethamine—PTGIR—smooth muscle tissue—urinary bladder cancer	0.00109	0.0156	CbGeAlD
Dinoprost Tromethamine—PTGIR—renal system—urinary bladder cancer	0.00105	0.015	CbGeAlD
Dinoprost Tromethamine—HPGDS—female reproductive system—urinary bladder cancer	0.00103	0.0148	CbGeAlD
Dinoprost Tromethamine—SLC22A11—renal system—urinary bladder cancer	0.00103	0.0147	CbGeAlD
Dinoprost Tromethamine—SLC22A7—renal system—urinary bladder cancer	0.001	0.0143	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—epithelium—urinary bladder cancer	0.000993	0.0142	CbGeAlD
Dinoprost Tromethamine—PTGFR—female reproductive system—urinary bladder cancer	0.000957	0.0137	CbGeAlD
Dinoprost Tromethamine—HPGDS—vagina—urinary bladder cancer	0.000936	0.0134	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—renal system—urinary bladder cancer	0.00093	0.0133	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—renal system—urinary bladder cancer	0.000921	0.0131	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—urethra—urinary bladder cancer	0.000913	0.013	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—urinary bladder cancer	0.00091	0.013	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—urethra—urinary bladder cancer	0.000904	0.0129	CbGeAlD
Dinoprost Tromethamine—SLC22A2—renal system—urinary bladder cancer	0.000892	0.0127	CbGeAlD
Dinoprost Tromethamine—SLC22A8—prostate gland—urinary bladder cancer	0.00085	0.0121	CbGeAlD
Dinoprost Tromethamine—PTGIR—female reproductive system—urinary bladder cancer	0.000844	0.012	CbGeAlD
Dinoprost Tromethamine—SLC22A11—female reproductive system—urinary bladder cancer	0.000822	0.0117	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female reproductive system—urinary bladder cancer	0.000744	0.0106	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female reproductive system—urinary bladder cancer	0.000737	0.0105	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—urinary bladder cancer	0.0007	0.01	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—vagina—urinary bladder cancer	0.000673	0.00962	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—vagina—urinary bladder cancer	0.000667	0.00952	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymph node—urinary bladder cancer	0.000605	0.00865	CbGeAlD
Dinoprost Tromethamine—Tafluprost—PTGS2—urinary bladder cancer	0.000592	0.312	CrCbGaD
Dinoprost Tromethamine—SLC22A8—renal system—urinary bladder cancer	0.000579	0.00827	CbGeAlD
Dinoprost Tromethamine—PTGFR—lymph node—urinary bladder cancer	0.00056	0.008	CbGeAlD
Dinoprost Tromethamine—PTGIR—lymph node—urinary bladder cancer	0.000493	0.00705	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lymph node—urinary bladder cancer	0.000436	0.00622	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—urinary bladder cancer	0.000431	0.00616	CbGeAlD
Dinoprost Tromethamine—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000169	0.00197	CcSEcCtD
Dinoprost Tromethamine—Cough—Gemcitabine—urinary bladder cancer	0.000168	0.00196	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Thiotepa—urinary bladder cancer	0.000168	0.00196	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000167	0.00195	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Gemcitabine—urinary bladder cancer	0.000166	0.00194	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Thiotepa—urinary bladder cancer	0.000166	0.00194	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—urinary bladder cancer	0.000164	0.00192	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Fluorouracil—urinary bladder cancer	0.000164	0.00192	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Gemcitabine—urinary bladder cancer	0.000164	0.00191	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000164	0.00191	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000163	0.0019	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Gemcitabine—urinary bladder cancer	0.000162	0.00189	CcSEcCtD
Dinoprost Tromethamine—Malaise—Cisplatin—urinary bladder cancer	0.000162	0.00189	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Fluorouracil—urinary bladder cancer	0.000161	0.00188	CcSEcCtD
Dinoprost Tromethamine—Pain—Thiotepa—urinary bladder cancer	0.00016	0.00187	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Fluorouracil—urinary bladder cancer	0.000159	0.00186	CcSEcCtD
Dinoprost Tromethamine—Back pain—Etoposide—urinary bladder cancer	0.000159	0.00186	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Etoposide—urinary bladder cancer	0.000158	0.00185	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000156	0.00182	CcSEcCtD
Dinoprost Tromethamine—Infection—Gemcitabine—urinary bladder cancer	0.000156	0.00182	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Cisplatin—urinary bladder cancer	0.000156	0.00182	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000154	0.0018	CcSEcCtD
Dinoprost Tromethamine—Infection—Fluorouracil—urinary bladder cancer	0.000154	0.00179	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Epirubicin—urinary bladder cancer	0.000153	0.00179	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000153	0.00178	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000153	0.00178	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000152	0.00177	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Cisplatin—urinary bladder cancer	0.000151	0.00176	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000151	0.00176	CcSEcCtD
Dinoprost Tromethamine—Malaise—Etoposide—urinary bladder cancer	0.000148	0.00173	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000148	0.00173	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000148	0.00173	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Gemcitabine—urinary bladder cancer	0.000147	0.00172	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000146	0.0017	CcSEcCtD
Dinoprost Tromethamine—Infection—Cisplatin—urinary bladder cancer	0.000146	0.0017	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000145	0.00169	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Fluorouracil—urinary bladder cancer	0.000144	0.00169	CcSEcCtD
Dinoprost Tromethamine—Cough—Etoposide—urinary bladder cancer	0.000144	0.00168	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Cisplatin—urinary bladder cancer	0.000143	0.00167	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Etoposide—urinary bladder cancer	0.000143	0.00166	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Epirubicin—urinary bladder cancer	0.000142	0.00166	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Etoposide—urinary bladder cancer	0.000142	0.00166	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—urinary bladder cancer	0.000142	0.00165	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000142	0.00165	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000141	0.00165	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00014	0.00164	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Etoposide—urinary bladder cancer	0.00014	0.00164	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Gemcitabine—urinary bladder cancer	0.00014	0.00163	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000139	0.00163	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000139	0.00162	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Etoposide—urinary bladder cancer	0.000138	0.00162	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000138	0.00161	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000138	0.00161	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Fluorouracil—urinary bladder cancer	0.000137	0.0016	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Cisplatin—urinary bladder cancer	0.000137	0.0016	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000135	0.00157	CcSEcCtD
Dinoprost Tromethamine—Pain—Gemcitabine—urinary bladder cancer	0.000134	0.00157	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Thiotepa—urinary bladder cancer	0.000134	0.00157	CcSEcCtD
Dinoprost Tromethamine—Infection—Etoposide—urinary bladder cancer	0.000133	0.00156	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—urinary bladder cancer	0.000132	0.00154	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Thiotepa—urinary bladder cancer	0.000132	0.00154	CcSEcCtD
Dinoprost Tromethamine—Pain—Fluorouracil—urinary bladder cancer	0.000132	0.00154	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Doxorubicin—urinary bladder cancer	0.000132	0.00154	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000132	0.00154	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Etoposide—urinary bladder cancer	0.000131	0.00153	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000131	0.00153	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00013	0.00152	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00013	0.00151	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000129	0.00151	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000128	0.00149	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000127	0.00149	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Methotrexate—urinary bladder cancer	0.000126	0.00147	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Etoposide—urinary bladder cancer	0.000125	0.00146	CcSEcCtD
Dinoprost Tromethamine—Pain—Cisplatin—urinary bladder cancer	0.000125	0.00146	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000124	0.00145	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Epirubicin—urinary bladder cancer	0.000124	0.00144	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Thiotepa—urinary bladder cancer	0.000124	0.00144	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000122	0.00143	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methotrexate—urinary bladder cancer	0.000121	0.00141	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000121	0.00141	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Etoposide—urinary bladder cancer	0.000121	0.00141	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Methotrexate—urinary bladder cancer	0.00012	0.0014	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Etoposide—urinary bladder cancer	0.00012	0.0014	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Etoposide—urinary bladder cancer	0.000119	0.00139	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—urinary bladder cancer	0.000119	0.00139	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Thiotepa—urinary bladder cancer	0.000119	0.00139	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Epirubicin—urinary bladder cancer	0.000118	0.00138	CcSEcCtD
Dinoprost Tromethamine—Rash—Thiotepa—urinary bladder cancer	0.000118	0.00138	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Thiotepa—urinary bladder cancer	0.000118	0.00137	CcSEcCtD
Dinoprost Tromethamine—Headache—Thiotepa—urinary bladder cancer	0.000117	0.00137	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000116	0.00135	CcSEcCtD
Dinoprost Tromethamine—Pain—Etoposide—urinary bladder cancer	0.000115	0.00134	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000115	0.00134	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—urinary bladder cancer	0.000114	0.00134	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000114	0.00133	CcSEcCtD
Dinoprost Tromethamine—Sweating—Epirubicin—urinary bladder cancer	0.000113	0.00132	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Gemcitabine—urinary bladder cancer	0.000113	0.00132	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Epirubicin—urinary bladder cancer	0.000112	0.00131	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Epirubicin—urinary bladder cancer	0.000111	0.0013	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Gemcitabine—urinary bladder cancer	0.000111	0.0013	CcSEcCtD
Dinoprost Tromethamine—Nausea—Thiotepa—urinary bladder cancer	0.000111	0.0013	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000111	0.00129	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00011	0.00128	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Fluorouracil—urinary bladder cancer	0.000109	0.00128	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000109	0.00127	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000108	0.00126	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—urinary bladder cancer	0.000108	0.00126	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000108	0.00126	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Etoposide—urinary bladder cancer	0.000106	0.00124	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Etoposide—urinary bladder cancer	0.000106	0.00124	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000106	0.00124	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000106	0.00123	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Cisplatin—urinary bladder cancer	0.000105	0.00123	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—urinary bladder cancer	0.000105	0.00122	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—urinary bladder cancer	0.000104	0.00122	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000103	0.0012	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—urinary bladder cancer	0.000103	0.0012	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000102	0.00119	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Fluorouracil—urinary bladder cancer	0.000102	0.00119	CcSEcCtD
Dinoprost Tromethamine—Chills—Methotrexate—urinary bladder cancer	0.000102	0.00119	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Cisplatin—urinary bladder cancer	0.0001	0.00117	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Gemcitabine—urinary bladder cancer	0.0001	0.00117	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—urinary bladder cancer	9.98e-05	0.00117	CcSEcCtD
Dinoprost Tromethamine—Rash—Gemcitabine—urinary bladder cancer	9.91e-05	0.00116	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Gemcitabine—urinary bladder cancer	9.9e-05	0.00116	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Etoposide—urinary bladder cancer	9.89e-05	0.00115	CcSEcCtD
Dinoprost Tromethamine—Headache—Gemcitabine—urinary bladder cancer	9.85e-05	0.00115	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Fluorouracil—urinary bladder cancer	9.83e-05	0.00115	CcSEcCtD
Dinoprost Tromethamine—Rash—Fluorouracil—urinary bladder cancer	9.75e-05	0.00114	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Fluorouracil—urinary bladder cancer	9.74e-05	0.00114	CcSEcCtD
Dinoprost Tromethamine—Headache—Fluorouracil—urinary bladder cancer	9.68e-05	0.00113	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Etoposide—urinary bladder cancer	9.63e-05	0.00112	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Epirubicin—urinary bladder cancer	9.61e-05	0.00112	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—urinary bladder cancer	9.57e-05	0.00112	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—urinary bladder cancer	9.53e-05	0.00111	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—urinary bladder cancer	9.5e-05	0.00111	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Etoposide—urinary bladder cancer	9.5e-05	0.00111	CcSEcCtD
Dinoprost Tromethamine—Nausea—Gemcitabine—urinary bladder cancer	9.34e-05	0.00109	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Cisplatin—urinary bladder cancer	9.32e-05	0.00109	CcSEcCtD
Dinoprost Tromethamine—Rash—Cisplatin—urinary bladder cancer	9.24e-05	0.00108	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Cisplatin—urinary bladder cancer	9.23e-05	0.00108	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Etoposide—urinary bladder cancer	9.19e-05	0.00107	CcSEcCtD
Dinoprost Tromethamine—Nausea—Fluorouracil—urinary bladder cancer	9.18e-05	0.00107	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—urinary bladder cancer	9.14e-05	0.00107	CcSEcCtD
Dinoprost Tromethamine—Back pain—Epirubicin—urinary bladder cancer	8.92e-05	0.00104	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—urinary bladder cancer	8.89e-05	0.00104	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—urinary bladder cancer	8.89e-05	0.00104	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Etoposide—urinary bladder cancer	8.88e-05	0.00104	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—urinary bladder cancer	8.86e-05	0.00104	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—urinary bladder cancer	8.85e-05	0.00103	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—urinary bladder cancer	8.79e-05	0.00103	CcSEcCtD
Dinoprost Tromethamine—Nausea—Cisplatin—urinary bladder cancer	8.7e-05	0.00102	CcSEcCtD
Dinoprost Tromethamine—Cough—Methotrexate—urinary bladder cancer	8.6e-05	0.001	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—urinary bladder cancer	8.56e-05	0.000999	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—urinary bladder cancer	8.54e-05	0.000997	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Etoposide—urinary bladder cancer	8.54e-05	0.000997	CcSEcCtD
Dinoprost Tromethamine—Agitation—Epirubicin—urinary bladder cancer	8.47e-05	0.000989	CcSEcCtD
Dinoprost Tromethamine—Rash—Etoposide—urinary bladder cancer	8.46e-05	0.000988	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Etoposide—urinary bladder cancer	8.46e-05	0.000987	CcSEcCtD
Dinoprost Tromethamine—Headache—Etoposide—urinary bladder cancer	8.41e-05	0.000982	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—urinary bladder cancer	8.39e-05	0.000979	CcSEcCtD
Dinoprost Tromethamine—Malaise—Epirubicin—urinary bladder cancer	8.31e-05	0.000971	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methotrexate—urinary bladder cancer	8.29e-05	0.000968	CcSEcCtD
Dinoprost Tromethamine—Syncope—Epirubicin—urinary bladder cancer	8.27e-05	0.000966	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—urinary bladder cancer	8.25e-05	0.000964	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—urinary bladder cancer	8.2e-05	0.000958	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—urinary bladder cancer	8.1e-05	0.000946	CcSEcCtD
Dinoprost Tromethamine—Cough—Epirubicin—urinary bladder cancer	8.05e-05	0.00094	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—urinary bladder cancer	7.99e-05	0.000933	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—urinary bladder cancer	7.99e-05	0.000933	CcSEcCtD
Dinoprost Tromethamine—Nausea—Etoposide—urinary bladder cancer	7.97e-05	0.000931	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—urinary bladder cancer	7.96e-05	0.00093	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	7.92e-05	0.000924	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—urinary bladder cancer	7.85e-05	0.000917	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—urinary bladder cancer	7.84e-05	0.000915	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—urinary bladder cancer	7.77e-05	0.000908	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—urinary bladder cancer	7.76e-05	0.000906	CcSEcCtD
Dinoprost Tromethamine—Malaise—Doxorubicin—urinary bladder cancer	7.69e-05	0.000898	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—urinary bladder cancer	7.65e-05	0.000893	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—urinary bladder cancer	7.51e-05	0.000877	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—urinary bladder cancer	7.5e-05	0.000876	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—urinary bladder cancer	7.48e-05	0.000873	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—urinary bladder cancer	7.44e-05	0.000869	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—urinary bladder cancer	7.4e-05	0.000865	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—urinary bladder cancer	7.39e-05	0.000863	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—urinary bladder cancer	7.37e-05	0.00086	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—urinary bladder cancer	7.34e-05	0.000858	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—urinary bladder cancer	7.27e-05	0.000849	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—urinary bladder cancer	7.26e-05	0.000848	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—urinary bladder cancer	7.22e-05	0.000843	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—urinary bladder cancer	7.18e-05	0.000838	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—urinary bladder cancer	7.17e-05	0.000837	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—urinary bladder cancer	7.15e-05	0.000835	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Epirubicin—urinary bladder cancer	7.03e-05	0.000821	CcSEcCtD
Dinoprost Tromethamine—Infection—Doxorubicin—urinary bladder cancer	6.92e-05	0.000808	CcSEcCtD
Dinoprost Tromethamine—Pain—Methotrexate—urinary bladder cancer	6.88e-05	0.000803	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—urinary bladder cancer	6.85e-05	0.0008	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—urinary bladder cancer	6.8e-05	0.000794	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—urinary bladder cancer	6.76e-05	0.000789	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	6.73e-05	0.000786	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—urinary bladder cancer	6.71e-05	0.000783	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—urinary bladder cancer	6.69e-05	0.000781	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—urinary bladder cancer	6.63e-05	0.000774	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	6.58e-05	0.000768	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—urinary bladder cancer	6.51e-05	0.00076	CcSEcCtD
Dinoprost Tromethamine—Pain—Epirubicin—urinary bladder cancer	6.44e-05	0.000751	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—urinary bladder cancer	6.36e-05	0.000742	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—urinary bladder cancer	6.36e-05	0.000742	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—urinary bladder cancer	6.25e-05	0.00073	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—urinary bladder cancer	6.21e-05	0.000725	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—urinary bladder cancer	6.2e-05	0.000724	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—urinary bladder cancer	6.19e-05	0.000723	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.15e-05	0.000719	CcSEcCtD
Dinoprost Tromethamine—Pain—Doxorubicin—urinary bladder cancer	5.95e-05	0.000695	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—urinary bladder cancer	5.95e-05	0.000695	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—urinary bladder cancer	5.95e-05	0.000695	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—urinary bladder cancer	5.92e-05	0.000692	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Methotrexate—urinary bladder cancer	5.77e-05	0.000674	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—urinary bladder cancer	5.74e-05	0.00067	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	5.69e-05	0.000665	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—urinary bladder cancer	5.69e-05	0.000664	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—urinary bladder cancer	5.54e-05	0.000647	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—urinary bladder cancer	5.5e-05	0.000643	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—urinary bladder cancer	5.5e-05	0.000643	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—urinary bladder cancer	5.5e-05	0.000642	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Epirubicin—urinary bladder cancer	5.4e-05	0.00063	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Epirubicin—urinary bladder cancer	5.32e-05	0.000622	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Methotrexate—urinary bladder cancer	5.32e-05	0.000621	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—urinary bladder cancer	5.15e-05	0.000601	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.13e-05	0.000599	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Methotrexate—urinary bladder cancer	5.11e-05	0.000597	CcSEcCtD
Dinoprost Tromethamine—Rash—Methotrexate—urinary bladder cancer	5.07e-05	0.000592	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—urinary bladder cancer	5.07e-05	0.000591	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—urinary bladder cancer	5.04e-05	0.000588	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—urinary bladder cancer	5e-05	0.000583	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Epirubicin—urinary bladder cancer	4.98e-05	0.000581	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—urinary bladder cancer	4.93e-05	0.000575	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Epirubicin—urinary bladder cancer	4.78e-05	0.000559	CcSEcCtD
Dinoprost Tromethamine—Nausea—Methotrexate—urinary bladder cancer	4.78e-05	0.000558	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—urinary bladder cancer	4.76e-05	0.000556	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—urinary bladder cancer	4.74e-05	0.000554	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Epirubicin—urinary bladder cancer	4.74e-05	0.000554	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—urinary bladder cancer	4.71e-05	0.00055	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—urinary bladder cancer	4.6e-05	0.000538	CcSEcCtD
Dinoprost Tromethamine—Nausea—Epirubicin—urinary bladder cancer	4.47e-05	0.000522	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Doxorubicin—urinary bladder cancer	4.43e-05	0.000517	CcSEcCtD
Dinoprost Tromethamine—Rash—Doxorubicin—urinary bladder cancer	4.39e-05	0.000513	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—urinary bladder cancer	4.39e-05	0.000512	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—urinary bladder cancer	4.36e-05	0.000509	CcSEcCtD
Dinoprost Tromethamine—Nausea—Doxorubicin—urinary bladder cancer	4.14e-05	0.000483	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TSC1—urinary bladder cancer	3.37e-05	0.000643	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NCOR1—urinary bladder cancer	3.34e-05	0.000637	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.33e-05	0.000636	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	3.28e-05	0.000626	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTO2—urinary bladder cancer	3.27e-05	0.000624	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NAT1—urinary bladder cancer	3.27e-05	0.000624	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—IL2—urinary bladder cancer	3.25e-05	0.000621	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—GPX1—urinary bladder cancer	3.25e-05	0.000621	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	3.21e-05	0.000612	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—JAG1—urinary bladder cancer	3.21e-05	0.000612	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ERCC2—urinary bladder cancer	3.19e-05	0.000609	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—urinary bladder cancer	3.15e-05	0.000601	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—RHOA—urinary bladder cancer	3.14e-05	0.000599	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CXCL8—urinary bladder cancer	3.09e-05	0.00059	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CXCL8—urinary bladder cancer	3.08e-05	0.000588	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—urinary bladder cancer	3.08e-05	0.000588	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—RHOA—urinary bladder cancer	3e-05	0.000574	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—MTHFR—urinary bladder cancer	3e-05	0.000573	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—UGT2B7—urinary bladder cancer	2.99e-05	0.00057	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL2—urinary bladder cancer	2.95e-05	0.000564	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TERT—urinary bladder cancer	2.94e-05	0.000562	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—KRAS—urinary bladder cancer	2.88e-05	0.00055	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—S100B—urinary bladder cancer	2.88e-05	0.00055	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.78e-05	0.00053	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—RHOA—urinary bladder cancer	2.73e-05	0.000521	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—RHOA—urinary bladder cancer	2.71e-05	0.000518	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FGFR3—urinary bladder cancer	2.7e-05	0.000515	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP4B1—urinary bladder cancer	2.69e-05	0.000514	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RBX1—urinary bladder cancer	2.68e-05	0.000511	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.64e-05	0.000504	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IL2—urinary bladder cancer	2.63e-05	0.000503	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ESR1—urinary bladder cancer	2.62e-05	0.000501	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RBX1—urinary bladder cancer	2.62e-05	0.000501	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RBX1—urinary bladder cancer	2.62e-05	0.000501	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—S100B—urinary bladder cancer	2.6e-05	0.000496	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NCOR1—urinary bladder cancer	2.59e-05	0.000494	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—urinary bladder cancer	2.56e-05	0.000489	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC19A1—urinary bladder cancer	2.54e-05	0.000485	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—IL2—urinary bladder cancer	2.52e-05	0.000481	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TSC1—urinary bladder cancer	2.52e-05	0.000481	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PRSS3—urinary bladder cancer	2.48e-05	0.000473	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TSC1—urinary bladder cancer	2.46e-05	0.000471	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TSC1—urinary bladder cancer	2.46e-05	0.000471	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—RHOA—urinary bladder cancer	2.46e-05	0.00047	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—HRAS—urinary bladder cancer	2.45e-05	0.000468	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.45e-05	0.000468	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PPARG—urinary bladder cancer	2.43e-05	0.000464	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—JAG1—urinary bladder cancer	2.4e-05	0.000458	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CXCL8—urinary bladder cancer	2.4e-05	0.000457	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.38e-05	0.000454	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—EP300—urinary bladder cancer	2.36e-05	0.000451	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—JAG1—urinary bladder cancer	2.35e-05	0.000448	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—JAG1—urinary bladder cancer	2.35e-05	0.000448	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CREBBP—urinary bladder cancer	2.34e-05	0.000446	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NCOR1—urinary bladder cancer	2.33e-05	0.000446	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SRC—urinary bladder cancer	2.3e-05	0.000439	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CREBBP—urinary bladder cancer	2.3e-05	0.000439	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL2—urinary bladder cancer	2.29e-05	0.000437	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TERT—urinary bladder cancer	2.28e-05	0.000436	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—IL2—urinary bladder cancer	2.27e-05	0.000434	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IGF1—urinary bladder cancer	2.27e-05	0.000433	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—EGFR—urinary bladder cancer	2.26e-05	0.000431	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.22e-05	0.000424	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CXCL8—urinary bladder cancer	2.16e-05	0.000413	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—KRAS—urinary bladder cancer	2.13e-05	0.000407	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FGFR3—urinary bladder cancer	2.09e-05	0.0004	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RHOA—urinary bladder cancer	2.08e-05	0.000397	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL2—urinary bladder cancer	2.06e-05	0.000394	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TERT—urinary bladder cancer	2.06e-05	0.000393	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ESR1—urinary bladder cancer	2.03e-05	0.000388	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—RHOA—urinary bladder cancer	2.03e-05	0.000387	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—RHOA—urinary bladder cancer	1.98e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.98e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TYMP—urinary bladder cancer	1.98e-05	0.000378	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—S100B—urinary bladder cancer	1.94e-05	0.000371	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ERBB2—urinary bladder cancer	1.92e-05	0.000367	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—urinary bladder cancer	1.91e-05	0.000365	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—KRAS—urinary bladder cancer	1.9e-05	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—S100B—urinary bladder cancer	1.9e-05	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—S100B—urinary bladder cancer	1.9e-05	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FGFR3—urinary bladder cancer	1.89e-05	0.000361	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.87e-05	0.000357	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—RHOA—urinary bladder cancer	1.84e-05	0.000351	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ESR1—urinary bladder cancer	1.83e-05	0.00035	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CXCL8—urinary bladder cancer	1.82e-05	0.000348	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HRAS—urinary bladder cancer	1.81e-05	0.000346	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—RHOA—urinary bladder cancer	1.8e-05	0.000344	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—RHOA—urinary bladder cancer	1.8e-05	0.000344	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NAT2—urinary bladder cancer	1.79e-05	0.000342	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CREBBP—urinary bladder cancer	1.78e-05	0.00034	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.78e-05	0.00034	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF1—urinary bladder cancer	1.76e-05	0.000336	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EGFR—urinary bladder cancer	1.75e-05	0.000334	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NCOR1—urinary bladder cancer	1.75e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL2—urinary bladder cancer	1.74e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.74e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.74e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NCOR1—urinary bladder cancer	1.71e-05	0.000326	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NCOR1—urinary bladder cancer	1.71e-05	0.000326	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—urinary bladder cancer	1.7e-05	0.000325	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCND1—urinary bladder cancer	1.7e-05	0.000325	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—urinary bladder cancer	1.69e-05	0.000323	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTEN—urinary bladder cancer	1.67e-05	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—urinary bladder cancer	1.66e-05	0.000318	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—IL2—urinary bladder cancer	1.66e-05	0.000318	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—KRAS—urinary bladder cancer	1.65e-05	0.000316	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP9—urinary bladder cancer	1.65e-05	0.000315	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.64e-05	0.000314	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTEN—urinary bladder cancer	1.64e-05	0.000313	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—HRAS—urinary bladder cancer	1.62e-05	0.000309	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—urinary bladder cancer	1.62e-05	0.000309	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RHOA—urinary bladder cancer	1.61e-05	0.000308	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CREBBP—urinary bladder cancer	1.61e-05	0.000307	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—EP300—urinary bladder cancer	1.59e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF1—urinary bladder cancer	1.59e-05	0.000303	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.58e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCL8—urinary bladder cancer	1.58e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—urinary bladder cancer	1.58e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EP300—urinary bladder cancer	1.56e-05	0.000299	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.56e-05	0.000298	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—RRM2—urinary bladder cancer	1.54e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL2—urinary bladder cancer	1.54e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TERT—urinary bladder cancer	1.54e-05	0.000294	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SRC—urinary bladder cancer	1.52e-05	0.000291	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL2—urinary bladder cancer	1.51e-05	0.000289	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL2—urinary bladder cancer	1.51e-05	0.000289	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TERT—urinary bladder cancer	1.51e-05	0.000288	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TERT—urinary bladder cancer	1.51e-05	0.000288	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ERBB2—urinary bladder cancer	1.49e-05	0.000285	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—KRAS—urinary bladder cancer	1.49e-05	0.000285	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.47e-05	0.000281	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RHOA—urinary bladder cancer	1.45e-05	0.000278	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ENO2—urinary bladder cancer	1.43e-05	0.000273	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	1.43e-05	0.000273	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCL8—urinary bladder cancer	1.41e-05	0.00027	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FGFR3—urinary bladder cancer	1.41e-05	0.00027	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HRAS—urinary bladder cancer	1.41e-05	0.000268	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	1.39e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FGFR3—urinary bladder cancer	1.38e-05	0.000264	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FGFR3—urinary bladder cancer	1.38e-05	0.000264	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ESR1—urinary bladder cancer	1.37e-05	0.000262	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MYC—urinary bladder cancer	1.36e-05	0.00026	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL2—urinary bladder cancer	1.35e-05	0.000258	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ERBB2—urinary bladder cancer	1.35e-05	0.000257	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ESR1—urinary bladder cancer	1.34e-05	0.000256	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ESR1—urinary bladder cancer	1.34e-05	0.000256	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—urinary bladder cancer	1.33e-05	0.000255	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCND1—urinary bladder cancer	1.32e-05	0.000252	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.3e-05	0.000248	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP9—urinary bladder cancer	1.28e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCL8—urinary bladder cancer	1.28e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDKN1A—urinary bladder cancer	1.28e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTEN—urinary bladder cancer	1.27e-05	0.000243	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—urinary bladder cancer	1.27e-05	0.000242	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KRAS—urinary bladder cancer	1.26e-05	0.000241	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL2—urinary bladder cancer	1.22e-05	0.000233	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EP300—urinary bladder cancer	1.21e-05	0.000232	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CREBBP—urinary bladder cancer	1.2e-05	0.000229	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCND1—urinary bladder cancer	1.19e-05	0.000227	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1—urinary bladder cancer	1.19e-05	0.000227	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—urinary bladder cancer	1.18e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SRC—urinary bladder cancer	1.18e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CREBBP—urinary bladder cancer	1.18e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CREBBP—urinary bladder cancer	1.18e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1—urinary bladder cancer	1.16e-05	0.000222	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1—urinary bladder cancer	1.16e-05	0.000222	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—urinary bladder cancer	1.16e-05	0.000221	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—urinary bladder cancer	1.16e-05	0.000221	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP9—urinary bladder cancer	1.15e-05	0.00022	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NQO1—urinary bladder cancer	1.15e-05	0.00022	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.15e-05	0.00022	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTEN—urinary bladder cancer	1.15e-05	0.000219	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	1.13e-05	0.000215	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—urinary bladder cancer	1.12e-05	0.000214	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—urinary bladder cancer	1.12e-05	0.000213	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EP300—urinary bladder cancer	1.09e-05	0.000209	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—urinary bladder cancer	1.09e-05	0.000209	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KRAS—urinary bladder cancer	1.09e-05	0.000209	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RHOA—urinary bladder cancer	1.09e-05	0.000208	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—urinary bladder cancer	1.07e-05	0.000205	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SRC—urinary bladder cancer	1.06e-05	0.000203	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RHOA—urinary bladder cancer	1.06e-05	0.000203	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RHOA—urinary bladder cancer	1.06e-05	0.000203	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MYC—urinary bladder cancer	1.06e-05	0.000202	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—urinary bladder cancer	1.03e-05	0.000197	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—urinary bladder cancer	1.01e-05	0.000192	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ERBB2—urinary bladder cancer	9.85e-06	0.000188	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—urinary bladder cancer	9.85e-06	0.000188	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KRAS—urinary bladder cancer	9.77e-06	0.000187	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	9.62e-06	0.000184	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—urinary bladder cancer	9.54e-06	0.000182	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MYC—urinary bladder cancer	9.54e-06	0.000182	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—urinary bladder cancer	9.48e-06	0.000181	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCL8—urinary bladder cancer	9.34e-06	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—urinary bladder cancer	9.34e-06	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—urinary bladder cancer	9.33e-06	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—urinary bladder cancer	9.28e-06	0.000177	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—urinary bladder cancer	9.28e-06	0.000177	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL2—urinary bladder cancer	9.12e-06	0.000174	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	8.94e-06	0.000171	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL2—urinary bladder cancer	8.93e-06	0.00017	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL2—urinary bladder cancer	8.93e-06	0.00017	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCND1—urinary bladder cancer	8.89e-06	0.00017	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	8.84e-06	0.000169	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	8.84e-06	0.000169	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KRAS—urinary bladder cancer	8.81e-06	0.000168	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCND1—urinary bladder cancer	8.7e-06	0.000166	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCND1—urinary bladder cancer	8.7e-06	0.000166	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—urinary bladder cancer	8.68e-06	0.000166	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP9—urinary bladder cancer	8.63e-06	0.000165	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN1A—urinary bladder cancer	8.6e-06	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTEN—urinary bladder cancer	8.58e-06	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	8.46e-06	0.000162	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP9—urinary bladder cancer	8.45e-06	0.000161	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP9—urinary bladder cancer	8.45e-06	0.000161	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN1A—urinary bladder cancer	8.42e-06	0.000161	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.42e-06	0.000161	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTEN—urinary bladder cancer	8.4e-06	0.00016	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTEN—urinary bladder cancer	8.4e-06	0.00016	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	8.31e-06	0.000159	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—urinary bladder cancer	8.3e-06	0.000159	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EP300—urinary bladder cancer	8.18e-06	0.000156	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EP300—urinary bladder cancer	8.01e-06	0.000153	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EP300—urinary bladder cancer	8.01e-06	0.000153	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SRC—urinary bladder cancer	7.96e-06	0.000152	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—urinary bladder cancer	7.83e-06	0.00015	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	7.81e-06	0.000149	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SRC—urinary bladder cancer	7.79e-06	0.000149	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SRC—urinary bladder cancer	7.79e-06	0.000149	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—urinary bladder cancer	7.49e-06	0.000143	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MYC—urinary bladder cancer	7.13e-06	0.000136	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MYC—urinary bladder cancer	6.98e-06	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MYC—urinary bladder cancer	6.98e-06	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—urinary bladder cancer	6.98e-06	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—urinary bladder cancer	6.83e-06	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—urinary bladder cancer	6.83e-06	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KRAS—urinary bladder cancer	6.59e-06	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KRAS—urinary bladder cancer	6.45e-06	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KRAS—urinary bladder cancer	6.45e-06	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	6.33e-06	0.000121	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	6.09e-06	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—urinary bladder cancer	5.86e-06	0.000112	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—urinary bladder cancer	5.73e-06	0.000109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—urinary bladder cancer	5.73e-06	0.000109	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—urinary bladder cancer	5.6e-06	0.000107	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—urinary bladder cancer	5.48e-06	0.000105	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—urinary bladder cancer	5.48e-06	0.000105	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	4.98e-06	9.52e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	4.35e-06	8.3e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—EP300—urinary bladder cancer	4.14e-06	7.91e-05	CbGpPWpGaD
